UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 22, 2018
Accession Number:
Submission Type:
CIK:
0000109657
Company Name:
GT Biopharma, Inc.
File Number:
333-223349